Redian新闻
>
上海干细胞工作机会
avatar
上海干细胞工作机会# Biology - 生物学
b*i
1
5个包子
12月31日过期,开saving with minimum opening deposit of $10,000
avatar
m*l
2
Shanghai Hengrui Pharmaceuticals Co., Ltd http://www.shhrp.com (China) is now seeking highly motivated professionals to fill the following positions.
Group leader(s), Principle Scientists in stem cell clinical product R&D
Responsibility:
The main responsibility is to develop stem cell products for clinical
purpose. You will lead a group of scientists (2+) and focus on platform set
up for stem cell isolation、characterization and differentiation;
preclinical standard set up for stem cell products; stem cell scale-up,
suspension culture、 application of biocompatible material (eg. polymer) in
stem cell product delivery; managing GMP stem cell facilities, et al. You
will collaboratively participate in work across Hengrui R&D center which is
highly dynamic and challenging environment. You are expected to
strategically think about project, provide scientific proposals and
effectively carry out on ongoing projects.
Requirements:
You should have a Ph.D. in cellular biology, cellular immunology or related
disciplines with 2+ year (postdoctoral) training and solid scientific
records. Hands-on experience in areas like stem cell (prefer adult stem cell
) isolation, culture, differentiation and characterization; umbilical cord
blood (UCB) and or bone marrow sample characterization; stem cell suspension
culture and scale up; biocompatible material development for stem cell
product delivery; stem cell GMP facility set-up, cGMP cell generation and or
cytokine-induced killer cell culture, et al. Demonstrated skills as a group
leader and expertise in stem cell culture, FACS, Real time PCR, confocal
microscope, immunostaining, iPS et al. You are flexible, high motivated and
innovative. You are good at communication and English.
We offer very competitive compensation package if interested, please forward
your resume to l***[email protected] Please make a note where you see this ad.
avatar
E*1
3
妈呀,要1W刀开户...
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。